The growth of the xerosis treatment market is expected to be driven by increasing awareness, enhanced diagnostic capabilities, and innovative product formulations, with a projected CAGR of 7.71% from 2025 to 2035

Market Research Future (MRFR) has published a cooked research report on the “xerosis treatment market” that contains the information from 2019 to 2035.

The Xerosis treatment market is projected to register a CAGR of 7.71% during the forecast period of 2025 to 2035.

MRFR recognizes the following companies as the key players in the xerosis treatment market are Bayer AG (Germany), Dr.Reddy’s Laboratories Ltd. (India), Johnson & Johnson Inc. (US), Galderma (Switzerland), Thornton & Ross Ltd. (UK), Amgen Inc. (US), Procter & Gamble (US), Unilever (UK), Pfizer Inc. (US), Cipla (India) and others

Market Highlights

The xerosis treatment market is expected to register a CAGR of 7.71% during the forecast period and is estimated to reach USD 82.45 billion by 2035.

The xerosis treatment market is growing due to factors like rising awareness and improved diagnosis of the condition. Increased public education through digital media and healthcare professionals has led to earlier symptom recognition and higher demand for timely treatments. Healthcare providers are also becoming better at diagnosing xerosis, especially in high-risk populations, which has expanded the use of both basic moisturizers and advanced prescription treatments, sparking innovation in the skincare and pharmaceutical industries.

The market's expansion is further driven by the aging population and the rise of self-care practices. Older adults are more prone to xerosis, increasing demand for specialized treatments, while the trend toward self-care encourages the use of over-the-counter solutions. Ongoing clinical research and studies are advancing new treatments, and rising disposable incomes are further boosting market growth. These factors are fostering innovation and creating opportunities for a wider range of treatments tailored to patients' needs.

Access full report @ https://www.marketresearchfuture.com/reports/xerosis-treatment-market-46310

Segment Analysis

The xerosis treatment market has a segment of type, form, age group, gender, and distribution channel.  

The xerosis treatment market is divided into two main segments: medication and personal care products. The medication segment includes antihistamines, corticosteroids, calcineurin inhibitors, anti-inflammatory drugs, immunomodulators, and others, each targeting different aspects of xerosis treatment based on the severity of the condition. The personal care products segment, which includes moisturizers, creams, and cleansers, held the largest market share in 2024 and focuses on maintaining hydration and preventing further skin damage. While the medication segment is growing rapidly, the personal care products segment remains the dominant treatment for daily management.

The market is further segmented by form, including tablets, lotions, creams, ointments, gels, shower foams, and others. Creams led the market in 2024 due to their effective moisture retention properties, while the shower foams segment is the fastest-growing. Tablets are driven by chronic conditions that cause severe dryness, while lotions offer lightweight, everyday solutions. Ointments are used for severe cases, and gels provide cooling effects, making them ideal for sensitive skin. Other formats like sprays, wipes, and oils cater to specific needs, further expanding the market.

Additionally, the market is segmented by age group, including pediatrics, adults, and the elderly. The adult segment dominated in 2023, driven by lifestyle factors like exposure to pollutants and dry environments. The elderly segment, which is the fastest growing, faces increased susceptibility to xerosis due to aging skin. Pediatric formulations are gaining popularity due to increasing cases of eczema and skin dryness in children, and the demand for hypoallergenic products is rising. The market also caters to gender-specific needs, with the female segment growing faster due to hormonal changes and greater use of skincare products, while the male segment is expanding as men become more proactive in skin health, influenced by evolving grooming trends.

In 2024, the female segment dominated the xerosis treatment market, driven by the higher prevalence of skin dryness among women, especially due to hormonal changes during pregnancy, menopause, and aging. Women are more likely to incorporate moisturizers and skincare products into their daily routines, which boosts the demand for xerosis treatments. With the availability of diverse product options and a growing focus on preventive skincare, women are increasingly turning to products that address skin hydration and barrier repair. The male segment, however, is the fastest-growing, as men become more proactive about skin health. Awareness campaigns and the increasing demand for gender-specific, non-greasy formulations tailored to men’s preferences are driving growth in this segment. Factors like sun exposure and occupational hazards further elevate the need for targeted treatments.

Regarding distribution channels, the offline segment held the largest market share in 2024, due to consumer trust in physical stores and the availability of professional guidance. Retail pharmacies, dermatology clinics, and hypermarkets remain vital, offering both prescription and over-the-counter products for various xerosis conditions. However, the online segment is growing rapidly, driven by the convenience and accessibility of e-commerce platforms. Online shopping enables consumers to browse, compare, and purchase products from home, with the added benefit of customer reviews and detailed product descriptions. The rise of online pharmacies further streamlines access to both prescription and over-the-counter treatments, enhancing the overall growth of the market during the forecast period.

Regional Analysis

The xerosis treatment market, based on region, has been divided into North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America further includes US, Canada, and Mexico. Europe includes countries namely Germany, France, UK, Italy, Spain, Italy, Russia, and the Rest of Europe. The Xerosis treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, Malaysia, Thailand, Indonesia, and the Rest of Asia-Pacific. Moreover, the South America comprises of Brazil, Mexico, Argentina, and Rest of South America and Middle East and Africa is divided into GCC Countries, South Africa, and Rest of MEA.

The xerosis treatment market in North America is driven by the rising incidence of skin disorders like eczema and psoriasis, particularly in the US and Canada. Increased awareness of skincare, coupled with a shift toward self-care and natural remedies, has fueled demand for both OTC and prescription treatments. The growth is supported by the availability of a wide range of treatment options and the growing e-commerce sector, alongside more dermatology clinics improving accessibility. The adoption of personalized skincare routines and organic products further contributes to market expansion. 

The European xerosis treatment market is growing due to the rising prevalence of skin conditions, especially among older populations. Countries like Germany, France, and the UK lead the market due to advanced healthcare systems and widespread access to dermatological treatments. Factors such as rising air pollution, aging populations, and the demand for natural and organic products are further shaping the market. A well-established OTC segment offers affordable solutions, while an increased focus on safe and sustainable skincare continues to drive demand.

The Asia-Pacific region is experiencing strong growth in xerosis treatments due to increased skin disorders in countries like Japan, China, and India, fueled by pollution, urbanization, and climate change. Rising health concerns and growing awareness about skincare are boosting demand for medical and personal care products. Additionally, the preference for dermatologically tested and natural ingredients, along with the increased availability of OTC treatments, are supporting the market's growth. A young, health-conscious population is driving demand for effective skincare solutions.

In South America, the xerosis treatment market is expanding rapidly due to dry skin issues resulting from environmental conditions like high temperatures and low humidity. Urbanization and improved healthcare access have driven the demand for medicinal and personal care products. Growing awareness of dermatological conditions and a shift toward natural, sustainable skincare products are further contributing to market growth. The rise of e-commerce platforms is also increasing the accessibility of skincare products across the region.

The xerosis treatment market in the Middle East and Africa is growing due to the prevalence of dry skin conditions exacerbated by the region's harsh climatic conditions. Increased awareness of dermatological issues, particularly in GCC countries, is boosting demand for skincare treatments. Growing urbanization in Africa, alongside better healthcare access, is further driving market growth. There is rising demand for both OTC and prescription treatments, with a preference for premium moisturizers in the Middle East and affordable products in Africa.

Key Findings of the Study

• 
  

  The xerosis treatment market is expected to reach USD 82.45 billion by 2035, at a CAGR of 7.71% during the forecast period.

  
  


• 
  

  The Europe region held the second largest market share of the global market in 2024 due to the growing awareness of skincare and xerosis management.

  
  


• 
  

  Based on form, the cream segment held the largest market with a market share of 32.17% in 2024 and shower foam is the fastest-growing segment during the forecast period.

  
  


• 
  

  Bayer AG (Germany), Dr.Reddy’s Laboratories Ltd. (India), Johnson & Johnson Inc. (US), Galderma (Switzerland), Thornton & Ross Ltd. (UK), Amgen Inc. (US), Procter & Gamble (US), Unilever (UK), Pfizer Inc. (US), Cipla (India) and others are the key players in the market.